Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vertex Ventures is a global network of venture capital funds that provides anchor funding and operational support to early-stage innovation companies. The firm's dedicated healthcare arm, Vertex Ventures HC, focuses on high-impact investments in the life sciences, including biopharmaceuticals, medical devices, and digital health. Vertex Ventures HC targets companies with transformative potential in therapeutic areas such as oncology, immunology, and rare diseases. By leveraging a global network and deep industry expertise, the firm helps its portfolio companies navigate the complexities of clinical development and regulatory approval. Vertex Ventures is a subsidiary of Vertex Venture Holdings, which is wholly owned by the Singapore-based investment company Temasek Holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vertex Venture Capital.